摘要
目的维甲酸类化合物能预防头颈部癌前病变转变为癌,并能有效地降低头颈部第二原发癌的发生率。近来研究证实,维甲酸对头颈部鳞癌有诱导分化治疗作用,但维甲酸对头颈部腺癌诱导分化作用研究少见报道。方法本研究采用克隆形成法、MTT检测法以及细胞周期测定技术,把全反式维甲酸(altransretinoicacidA-TRA)对人涎腺腺样囊性癌细胞株(AccM)的体外抗增殖作用和细胞增殖周期进行了观察。结果显示,ATRA对AccM细胞有一定抗增殖作用,且该作用与浓度、时间呈依赖关系;AccM细胞经ATRA作用72小时后其S期比例明显下降,同时G0+G1期比例上升。结论研究表明,5~20μmol/L浓度的ATRA对AccM细胞产生抗增殖作用。
Retinoids are proved to prevent carcinogenesis in head and neck premalignant lesions and to prevent second primary carcinoma in patients with head and neck cancer. Recent studies have demonstrated the efficacy of retinoic acid in inducing differentiation therapy of carcinoma. In the present study, all trans retinoic acid was tested for its antiproliferative activity aganist human salivary adenoid cystic carcinoma cell(AccM) in vitro. Clonogenic assay and MTT assay as well as cell cycle analysis were used in this experiment. These observations showed that ATRA can inhibit the growth of AccM cell with does and time response manner. The decrease in proportions of cells in Sphase was detected following 72 h of treatment, this was accompanied by an increase of cell in G0 and G1. These results indicated that proliferation of AccM can be inhibited by higher concentrations of ATRE.
出处
《口腔颌面外科杂志》
CAS
1998年第1期12-14,共3页
Journal of Oral and Maxillofacial Surgery
基金
国家自然科学基金
关键词
涎腺
腺样囊性癌
全反式维甲酸
治疗
抗增殖
AccM cell line All trans retinoic acid Antiproliferation Induced differentiation therapy